<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Molecules</journal-id><journal-id journal-id-type="iso-abbrev">Molecules</journal-id><journal-id journal-id-type="publisher-id">molecules</journal-id><journal-title-group><journal-title>Molecules</journal-title></journal-title-group><issn pub-type="epub">1420-3049</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6278459</article-id><article-id pub-id-type="doi">10.3390/molecules23112974</article-id><article-id pub-id-type="publisher-id">molecules-23-02974</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Antitumor Effect of the Essential Oil from the Leaves of <italic>Croton</italic>
<italic>matourensis</italic> Aubl. (Euphorbiaceae)</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>de Lima</surname><given-names>Emilly J. S. P.</given-names></name><xref ref-type="aff" rid="af1-molecules-23-02974">1</xref><xref ref-type="author-notes" rid="fn1-molecules-23-02974">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Alves</surname><given-names>Rafaela G.</given-names></name><xref ref-type="aff" rid="af2-molecules-23-02974">2</xref><xref ref-type="author-notes" rid="fn1-molecules-23-02974">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>D&#x000b4;Elia</surname><given-names>Gigliola M. A.</given-names></name><xref ref-type="aff" rid="af1-molecules-23-02974">1</xref></contrib><contrib contrib-type="author"><name><surname>da Anuncia&#x000e7;&#x000e3;o</surname><given-names>Talita A.</given-names></name><xref ref-type="aff" rid="af2-molecules-23-02974">2</xref></contrib><contrib contrib-type="author"><name><surname>Silva</surname><given-names>Valdenizia R.</given-names></name><xref ref-type="aff" rid="af2-molecules-23-02974">2</xref></contrib><contrib contrib-type="author"><name><surname>Santos</surname><given-names>Luciano de S.</given-names></name><xref ref-type="aff" rid="af2-molecules-23-02974">2</xref></contrib><contrib contrib-type="author"><name><surname>Soares</surname><given-names>Milena B. P.</given-names></name><xref ref-type="aff" rid="af2-molecules-23-02974">2</xref><xref ref-type="aff" rid="af3-molecules-23-02974">3</xref></contrib><contrib contrib-type="author"><name><surname>Cardozo</surname><given-names>N&#x000e1;llarett M. D.</given-names></name><xref ref-type="aff" rid="af4-molecules-23-02974">4</xref></contrib><contrib contrib-type="author"><name><surname>Costa</surname><given-names>Emmanoel V.</given-names></name><xref ref-type="aff" rid="af5-molecules-23-02974">5</xref></contrib><contrib contrib-type="author"><name><surname>da Silva</surname><given-names>Felipe M. A.</given-names></name><xref ref-type="aff" rid="af5-molecules-23-02974">5</xref></contrib><contrib contrib-type="author"><name><surname>Koolen</surname><given-names>Hector H. F.</given-names></name><xref ref-type="aff" rid="af1-molecules-23-02974">1</xref><xref rid="c1-molecules-23-02974" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6774-2063</contrib-id><name><surname>Bezerra</surname><given-names>Daniel P.</given-names></name><xref ref-type="aff" rid="af2-molecules-23-02974">2</xref><xref rid="c1-molecules-23-02974" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-molecules-23-02974"><label>1</label>Metabolomics and Mass Spectrometry Research Group, Amazonas State University (UEA), Manaus, Amazonas, 690065-130, Brazil; <email>emillyjulianasales@gmail.com</email> (E.J.S.P.d.L.); <email>gigliolamayara@gmail.com</email> (G.M.A.D.)</aff><aff id="af2-molecules-23-02974"><label>2</label>Gon&#x000e7;alo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), Salvador, Bahia, 40296-710, Brazil; <email>rafalves09@gmail.com</email> (R.G.A.); <email>tali.andrade36@gmail.com</email> (T.A.d.A.); <email>valdeniziar@gmail.com</email> (V.R.S.); <email>luciano.biomed@gmail.com</email> (L.d.S.S.); <email>milena@bahia.fiocruz.br</email> (M.B.P.S.)</aff><aff id="af3-molecules-23-02974"><label>3</label>Center of Biotechnology and Cell Therapy, Hospital S&#x000e3;o Rafael, Salvador, Bahia, 41253-190, Brazil</aff><aff id="af4-molecules-23-02974"><label>4</label>Amazonia Museum (MUSA), Manaus, Amazonas, 69099-415, Brazil; <email>nallarett.davila@gmail.com</email></aff><aff id="af5-molecules-23-02974"><label>5</label>Department of Chemistry, Federal University of Amazonas (UFAM), Manaus, Amazonas, 69077-000, Brazil; <email>emmanoelvc@gmail.com</email> (E.V.C.) <email>felipesaquarema@bol.com.br</email> (F.M.A.d.S.)</aff><author-notes><corresp id="c1-molecules-23-02974"><label>*</label>Corresponding: <email>hkoolen@uea.edu.br</email> (H.H.F.K.); <email>danielpbezerra@gmail.com</email> (D.P.B.); Tel. + 55 71 3176 2272 (D.P.B.)</corresp><fn id="fn1-molecules-23-02974"><label>&#x02020;</label><p>These authors contributed equally.</p></fn></author-notes><pub-date pub-type="epub"><day>14</day><month>11</month><year>2018</year></pub-date><pub-date pub-type="collection"><month>11</month><year>2018</year></pub-date><volume>23</volume><issue>11</issue><elocation-id>2974</elocation-id><history><date date-type="received"><day>31</day><month>10</month><year>2018</year></date><date date-type="accepted"><day>12</day><month>11</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; 2018 by the authors.</copyright-statement><copyright-year>2018</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p><italic>Croton matourensis</italic> Aubl. (synonym <italic>Croton lanjouwensis</italic> Jabl.), popularly known as &#x0201c;orelha de burro&#x0201d;, &#x0201c;maravuvuia&#x0201d;, and/or &#x0201c;sangrad&#x02019;&#x000e1;gua&#x0201d;, is a medicinal plant used in Brazilian folk medicine as a depurative and in the treatment of infections, fractures, and colds. In this work, we investigated the chemical composition and in vitro cytotoxic and in vivo antitumor effects of the essential oil (EO) from the leaves of <italic>C. matourensis</italic> collected from the Amazon rainforest. The EO was obtained by hydrodistillation using a Clevenger-type apparatus and characterized qualitatively and quantitatively by gas chromatography coupled to mass spectrometry (GC&#x02013;MS) and gas chromatography with flame ionization detection (GC&#x02013;FID), respectively. In vitro cytotoxicity of the EO was assessed in cancer cell lines (MCF-7, HCT116, HepG2, and HL-60) and the non-cancer cell line (MRC-5) using the Alamar blue assay. Furthermore, annexin V-FITC/PI staining and the cell cycle distribution were evaluated with EO-treated HepG2 cells by flow cytometry. In vivo efficacy of the EO (40 and 80 mg/kg/day) was demonstrated in C.B-17 severe combined <italic/>immunodeficient (SCID) mice with HepG2 cell xenografts. The EO included &#x003b2;-caryophyllene, thunbergol, cembrene, <italic>p</italic>-cymene, and &#x003b2;-elemene as major constituents. The EO exhibited promising cytotoxicity and was able to cause phosphatidylserine externalization and DNA fragmentation without loss of the cell membrane integrity in HepG2 cells. In vivo tumor mass inhibition rates of the EO were 34.6% to 55.9%. Altogether, these data indicate the anticancer potential effect of <italic>C. matourensis</italic>.</p></abstract><kwd-group><kwd><italic>Croton matourensis</italic></kwd><kwd><italic>Croton lanjouwensis</italic></kwd><kwd>antitumor</kwd><kwd>apoptosis</kwd><kwd>HepG2</kwd></kwd-group></article-meta></front><body><sec id="sec1-molecules-23-02974"><title>1. Introduction</title><p>The genus <italic>Croton</italic> (family Euphorbiaceae) contains approximately 1300 species that are found in tropical and subtropical regions of the world [<xref rid="B1-molecules-23-02974" ref-type="bibr">1</xref>]. Plants from this genus have been used in the folk medicine to treat cancer, which include <italic>C. palanostigma</italic> Klotzsch [<xref rid="B2-molecules-23-02974" ref-type="bibr">2</xref>,<xref rid="B3-molecules-23-02974" ref-type="bibr">3</xref>], <italic>C. lechleri</italic> M&#x000fc;ll. Arg. [<xref rid="B4-molecules-23-02974" ref-type="bibr">4</xref>] and <italic>C. tiglium</italic> L. [<xref rid="B5-molecules-23-02974" ref-type="bibr">5</xref>]. Moreover, numerous plants belonging to this genus have been reported with cytotoxic and antitumor potentials, including <italic>C. palanostigma</italic> Klotzsch [<xref rid="B2-molecules-23-02974" ref-type="bibr">2</xref>], <italic>C. regelianus</italic> M&#x000fc;ll. Arg. [<xref rid="B6-molecules-23-02974" ref-type="bibr">6</xref>], <italic>C. lechleri</italic> M&#x000fc;ll. Arg. [<xref rid="B7-molecules-23-02974" ref-type="bibr">7</xref>], <italic>C. urucurana</italic> Baill. [<xref rid="B8-molecules-23-02974" ref-type="bibr">8</xref>], <italic>C. betulaster</italic> M&#x000fc;ll. Arg. [<xref rid="B9-molecules-23-02974" ref-type="bibr">9</xref>], <italic>C. tiglium</italic> L. [<xref rid="B10-molecules-23-02974" ref-type="bibr">10</xref>] and <italic>C. crassifolius</italic> Geiseler [<xref rid="B11-molecules-23-02974" ref-type="bibr">11</xref>].</p><p><italic>Croton matourensis</italic> Aubl. (synonym <italic>Croton lanjouwensis</italic> Jabl.) is a tree widely spread in the Amazon rainforest and in some regions of Central America (Panama). In Brazil, it is popularly known as &#x0201c;orelha de burro&#x0201d;, &#x0201c;maravuvuia&#x0201d;, and/or &#x0201c;sangrad&#x02019;&#x000e1;gua&#x0201d;, and is used in folk medicine as a depurative and in the treatment of infections, fractures, and colds [<xref rid="B12-molecules-23-02974" ref-type="bibr">12</xref>,<xref rid="B13-molecules-23-02974" ref-type="bibr">13</xref>,<xref rid="B14-molecules-23-02974" ref-type="bibr">14</xref>,<xref rid="B15-molecules-23-02974" ref-type="bibr">15</xref>]. However, only few research papers are found for this species [<xref rid="B16-molecules-23-02974" ref-type="bibr">16</xref>,<xref rid="B17-molecules-23-02974" ref-type="bibr">17</xref>,<xref rid="B18-molecules-23-02974" ref-type="bibr">18</xref>,<xref rid="B19-molecules-23-02974" ref-type="bibr">19</xref>]. <italic>&#x003b1;</italic>-Pinene, elemecine, <italic>&#x003b1;</italic>-phellandrene, <italic>p</italic>-cymene, linalool, and <italic>&#x003b2;</italic>-caryophyllene were found as the main constituents in the essential oil (EO) from the leaves, fruit, inflorescence, and bark of <italic>C. matourensis</italic> collected from the Brazilian Amazon rainforest [<xref rid="B16-molecules-23-02974" ref-type="bibr">16</xref>,<xref rid="B17-molecules-23-02974" ref-type="bibr">17</xref>]. Additionally, the seco-labdane diterpene named maravuic acid was isolated from the bark of <italic>C. matourensis</italic> [<xref rid="B18-molecules-23-02974" ref-type="bibr">18</xref>]. More recently, the chemical composition and cytotoxic activity of the EO from the leaves of <italic>C. matourensis</italic> collected in Venezuela were reported [<xref rid="B19-molecules-23-02974" ref-type="bibr">19</xref>], in which fenchyl acetate, methyleugenol, isoelemicine, elemicine, spathulenol, and valencene were found as main constituents, and cytotoxic potential was observed in LoVo (human colon carcinoma) and HeLa (human cervical cancer) cell lines [<xref rid="B19-molecules-23-02974" ref-type="bibr">19</xref>]. However, in vivo antitumor properties have not been investigated. In this work, we investigated the chemical composition, in vitro cytotoxicity, and in vivo antitumor effect of the EO obtained from the leaves of <italic>C. matourensis</italic> collected from the Amazon rainforest.</p></sec><sec id="sec2-molecules-23-02974"><title>2. Results</title><sec id="sec2dot1-molecules-23-02974"><title>2.1. Chemical Composition of the Essential Oil</title><p>The EO recovery from the leaves of <italic>C. matourensis</italic> was 0.34 &#x000b1; 0.03% (<italic>w</italic>/<italic>w</italic>) and its chemical composition is presented in <xref rid="molecules-23-02974-t001" ref-type="table">Table 1</xref>. The terpenoid class fully dominated the EO sample composition, in which, sesquiterpenes were the main representatives (46.53%), followed by diterpenes (26.94%), and monoterpenes (25.02%). Among them, 42 (representing 90.00% of the EO) were identified based on their retention indexes and mass spectral-fragments. The major compounds in the EO were &#x003b2;-caryophyllene (12.41 &#x000b1; 1.02%), thunbergol (11.74 &#x000b1; 1.11%), cembrene (7.12 &#x000b1; 0.55%), <italic>p</italic>-cymene (5.05 &#x000b1; 0.49%), and &#x003b2;-elemene (4.94 &#x000b1; 0.35%).</p></sec><sec id="sec2dot2-molecules-23-02974"><title>2.2. In Vitro Cytotoxicity</title><p>In vitro cytotoxicity of the EO from the leaves of <italic>C. matourensis</italic> to human cancer cell lines MCF-7 (breast adenocarcinoma), HCT116 (colon carcinoma), HepG2 (hepatocellular carcinoma), HL-60 (promyelocytic leukemia), and human non-cancer cell line MRC-5 (lung fibroblasts) was assessed by the Alamar blue assay after 72 h of treatment. <xref rid="molecules-23-02974-t002" ref-type="table">Table 2</xref> presents the half maximal inhibitory concentrations (IC<sub>50</sub>) obtained. The EO displayed an IC<sub>50</sub> value of 23.3 &#x000b5;g/mL for MCF-7, 28.9 &#x000b5;g/mL for HCT116, 28.5 &#x000b5;g/mL for HepG2, 17.8 &#x000b5;g/mL for HL-60, and 25.8 &#x000b5;g/mL for MRC-5. Doxorubicin was used as the positive control and showed an IC<sub>50</sub> value of 0.3 &#x000b5;g/mL for MCF-7, 0.1 &#x000b5;g/mL for HCT116, 0.03 &#x000b5;g/mL for HepG2, 0.04 &#x000b5;g/mL for HL-60, and 0.2 &#x000b5;g/mL for MRC-5.</p><p>Then, we quantified the cell viability using annexin V-FITC and PI double staining, and the cell fluorescence was measured by flow cytometry to determine the percentage of HepG2 cells in viable (cells that are annexin V-FITC/PI double-negative), early apoptotic (cells that are annexin V-FITC-positive and PI-negative), late apoptotic (cells that are annexin V-FITC/PI double-positive), and necrotic (cells that are annexin V-FITC-negative and PI-positive) stages after 48 h of treatment with the EO at concentrations of 12.5, 25, and 50 &#x000b5;g/mL, as shown in <xref ref-type="fig" rid="molecules-23-02974-f001">Figure 1</xref>. These concentrations were based at the IC<sub>50</sub> value (28.5 &#x000b5;g/mL) of the EO for HepG2 cells, and since the doubling time of HepG2 cell is about 48 h, we used this time of treatment to evaluate the effect of the EO after one full cell cycle. The EO treatment caused an increase of the apoptotic (early + late apoptotic cells) cell death after 48 h of treatment (<italic>P</italic> &#x0003c; 0.05). No increase in the necrotic (annexin V-FITC-negative/PI-positive) cells was observed (<italic>P</italic> &#x0003e; 0.05). Doxorubicin also led to an increase of the apoptotic cells (<italic>P</italic> &#x0003c; 0.05). At the concentrations of 12.5, 25, and 50 &#x003bc;g/mL, the EO increased the apoptotic cell death to 12.1%, 23.6%, and 25.7%, against 6.3% observed at the control group. Doxorubicin, at 1 &#x003bc;g/mL, increased the apoptosis to 20.7%.</p><p>The cell cycle distribution in the EO-treated HepG2 cells was performed by the DNA content using flow cytometry after 48 h of treatment, as shown in <xref ref-type="fig" rid="molecules-23-02974-f002">Figure 2</xref>. All DNA that was sub-diploid in size (sub-G<sub>0</sub>/G<sub>1</sub>) was considered fragmented. EO-treated HepG2 cells presented an internucleosomal DNA fragmentation significantly increased (<italic>P</italic> &#x0003c; 0.05). Doxorubicin also significantly induced internucleosomal DNA fragmentation (<italic>P</italic> &#x0003c; 0.05). At the concentrations of 12.5, 25, and 50 &#x003bc;g/mL, the EO increased the DNA fragmentation to 10.0%, 13.2%, and 40.5%, against 7.0% observed at the control group. Doxorubicin, at 1 &#x003bc;g/mL, increased the DNA fragmentation to 22.4%. The cell cycle phases G<sub>0</sub>/G<sub>1</sub>, S, and G<sub>2</sub>/M were reduced proportionally.</p></sec><sec id="sec2dot3-molecules-23-02974"><title>2.3. In Vivo Antitumor Activity</title><p>In vivo antitumor effect of the EO from the leaves of <italic>C. matourensis</italic> was assessed in C.B-17 severe combined <italic/>immunodeficient (SCID) mice with HepG2 cell xenografts. Animals were treated with the EO at doses of 40 and 80 mg/kg/day through intraperitoneal injections delivered once a day for 21 consecutive days. At the end of the treatment, the mean tumor mass weight of the negative control animals was 0.5 &#x000b1; 0.1 g, as shown in <xref ref-type="fig" rid="molecules-23-02974-f003">Figure 3</xref>A. In the EO-treated animals, the mean tumor mass weights were 0.3 &#x000b1; 0.1 g at 40 mg/kg/day dosage and 0.2 &#x000b1; 0.03 g at 80 mg/kg/day dosage. Tumor mass inhibition rates of the EO were 34.6% to 55.9% (<italic>P</italic> &#x0003c; 0.05), as shown in <xref ref-type="fig" rid="molecules-23-02974-f003">Figure 3</xref>B. In this study, 5-fluorouracil at the dosage of 10 mg/kg/day was used as the positive control, which reduced the tumor weight by 44.2%.</p><p>In regard to the toxicological parameters investigated, no significant changes on body and organs (liver, kidney, lung, and heart) weight were seen on the EO-treated groups (<italic>P</italic> &#x0003e; 0.05), as shown in <xref rid="molecules-23-02974-t003" ref-type="table">Table 3</xref>. Hematological parameters of the peripheral blood drawn from C.B-17 SCID mice with HepG2 cell xenografts were also analyzed, as shown in <xref rid="molecules-23-02974-t004" ref-type="table">Table 4</xref>. Although some variations have been observed, no statistically significant alteration was found in the hematological parameters in the animals treated with the EO (<italic>P</italic> &#x0003e; 0.05).</p></sec></sec><sec id="sec3-molecules-23-02974"><title>3. Discussion</title><p>In this study, antitumor effect of the EO from the leaves of <italic>C. matourensis</italic> was reported for the first time at this communication. As mentioned above, a previous study investigated the chemical composition and cytotoxic activity of the EO from the leaves of <italic>C. matourensis</italic> collected in Venezuela [<xref rid="B19-molecules-23-02974" ref-type="bibr">19</xref>]. These authors found fenchyl acetate, methyleugenol, isoelemicine, elemicine, spathulenol, and valencene as the main constituents of this EO<italic>.</italic> Moreover, previous studies with the EO from the leaves, fruit, inflorescence, and bark of <italic>C. matourensis</italic> collected from the Brazilian Amazon rainforest presented <italic>&#x003b1;</italic>-pinene, elemecine, &#x003b1;-phellandrene, <italic>p</italic>-cymene, linalool, and &#x003b2;-caryophyllene as the main constituents [<xref rid="B16-molecules-23-02974" ref-type="bibr">16</xref>,<xref rid="B17-molecules-23-02974" ref-type="bibr">17</xref>]. Herein, we observed a different chemical composition of the EO for <italic>C. matourensis</italic> in comparison with individuals collected in Venezuela, where &#x003b2;-caryophyllene, thunbergol, cembrene, <italic>p</italic>-cymene, and &#x003b2;-elemene were found as major constituents. Interestingly, when compared to with a specimen collected in central Amazonia, especially, in Brazil, a similar chemical composition is observed.</p><p>In the work of Compagnone et al. [<xref rid="B19-molecules-23-02974" ref-type="bibr">19</xref>], the EO from the leaves of <italic>C. matourensis</italic> caused cytotoxicity in LoVo (human colon carcinoma) and HeLa (human cervical cancer) cell lines with IC<sub>50</sub> values of 36.6 and 83.9 &#x003bc;g/mL, respectively, while inducing cytotoxicity in human dermis fibroblasts cells with an IC<sub>50</sub> value of 132.7 &#x003bc;g/mL. In this work, we observed similar results where the EO was cytotoxic with IC<sub>50</sub> values of 23.3 &#x000b5;g/mL for MCF-7, 28.9 &#x000b5;g/mL for HCT116, 28.5 &#x000b5;g/mL for HepG2, 17.8 &#x000b5;g/mL for HL-60, and 25.8 &#x000b5;g/mL for MRC-5.</p><p>In our cytotoxic screening program, EO with IC<sub>50</sub> values below 30 &#x003bc;g/mL are considered promising for cancer drug development [<xref rid="B20-molecules-23-02974" ref-type="bibr">20</xref>,<xref rid="B21-molecules-23-02974" ref-type="bibr">21</xref>,<xref rid="B22-molecules-23-02974" ref-type="bibr">22</xref>]. Therefore, the results obtained with the EO from the leaves of <italic>C. matourensis</italic> should be explored further. These data corroborate with previous results observed with EO obtained from <italic>Croton</italic> species. The EO from the leaves of <italic>C. flavens</italic> showed cytotoxicity in A-549 (human lung carcinoma) and DLD-1 (human colon adenocarcinoma) cells with IC<sub>50</sub> values of 27 and 28 &#x003bc;g/mL, respectively [<xref rid="B23-molecules-23-02974" ref-type="bibr">23</xref>]. The EO from the leaves of <italic>C. regelianus</italic> induced cytotoxic effect in HL-60, HCT-8 (human colon carcinoma), SF295 (human glioblastoma), MDA-MB-435 (human melanoma) cells, with IC<sub>50</sub> values of 22.2, 40.0, 48.0, and 47.3 &#x003bc;g/mL, respectively [<xref rid="B6-molecules-23-02974" ref-type="bibr">6</xref>]. The EO obtained from leaves of <italic>C. campestres</italic> exhibited cytotoxicity in MCF-7 and HT-29 (human colon adenocarcinoma) cells with IC<sub>50</sub> values of 8.61 and 9.94 &#x003bc;g/mL, respectively [<xref rid="B24-molecules-23-02974" ref-type="bibr">24</xref>].</p><p>Concerning the main constituents of the EO from the leaves of <italic>C. matourensis,</italic> some of them, e.g., &#x003b2;-caryophyllene, cembrene, <italic>p</italic>-cymene, and &#x003b2;-elemene, have been reported as cytotoxic agents [<xref rid="B22-molecules-23-02974" ref-type="bibr">22</xref>,<xref rid="B25-molecules-23-02974" ref-type="bibr">25</xref>,<xref rid="B26-molecules-23-02974" ref-type="bibr">26</xref>,<xref rid="B27-molecules-23-02974" ref-type="bibr">27</xref>,<xref rid="B28-molecules-23-02974" ref-type="bibr">28</xref>], indicating that the mixture of them are associated with the cytotoxic and antitumor properties of this EO.</p><p>Phosphatidylserine externalization and DNA fragmentation, without loss of the cell membrane integrity, are cellular biochemical alterations that are often correlated with the apoptotic cell death [<xref rid="B29-molecules-23-02974" ref-type="bibr">29</xref>]. Herein, we observed that the EO from the leaves of <italic>C. matourensis</italic> increased the phosphatidylserine exposure and internucleosomal DNA, without causing alterations in the cell membrane integrity (no increase in the PI-positive cells was observed). Moreover, the EO from the leaves of <italic>Lippia gracilis, Guatteria blepharophylla</italic>, and <italic>Guatteria hispida</italic> inhibited cell proliferation and induced cell death by apoptosis in HepG2 cells [<xref rid="B25-molecules-23-02974" ref-type="bibr">25</xref>,<xref rid="B30-molecules-23-02974" ref-type="bibr">30</xref>]. The EO from the aerial parts of <italic>Salvia aurea</italic>, <italic>S. judaica,</italic> and <italic>S. viscosa</italic> caused the apoptosis process and increasing reactive oxygen species in DU-145 (human prostate cancer) cells [<xref rid="B31-molecules-23-02974" ref-type="bibr">31</xref>]. The EO from the leaves of <italic>Pinus roxburghii</italic> induced apoptosis along with inhibition of NF-<italic>&#x003ba;</italic>B and inhibited the expression of genes associated to cell survival (survivin, c-FLIP, Bcl-2, Bcl-xL, c-Myc, c-IAP2), proliferation (cyclin D1), and metastasis (MMP-9) in KBM-5 (chronic myeloid leukemia) cells [<xref rid="B32-molecules-23-02974" ref-type="bibr">32</xref>].</p><p>In addition, we demonstrated that the EO from the leaves of <italic>C. matourensis</italic> has in vivo antitumor effect in C.B-17 SCID mice with HepG2 cell xenografts. The antitumor effect of the EO from the leaves of <italic>C. regelianus</italic> has been previously reported using sarcoma 180 as tumor model, while the EO inhibited the tumor development by 28.1% and 31.8%, at doses of 50 and 100 mg/kg/day, and the ascaridole, one of its main constituents, inhibited the tumor development by 33.9% and 33.3%, at doses of 10 and 20 mg/kg/day, respectively [<xref rid="B6-molecules-23-02974" ref-type="bibr">6</xref>]. Herein, the EO from the leaves of <italic>C. matourensis</italic> inhibited the tumor mass by 34.6% to 55.9% at doses of 40 and 80 mg/kg/day, respectively, and although the EO was less potent than the positive control 5-fluorouracil, the EO presented similar or superior efficacy to that observed for it. The positive control 5-fluorouracil inhibited the tumor mass by 44.2% at a dose of 10 mg/kg/day.</p><p>In conclusion, the EO from the leaves of <italic>C. matourensis</italic> has &#x003b2;-caryophyllene, thunbergol, cembrene, <italic>p</italic>-cymene, and &#x003b2;-elemene as major constituents. Moreover, the EO has an in vitro and in vivo anti-liver cancer effect. These data indicate the anticancer potential effect of this plant.</p></sec><sec id="sec4-molecules-23-02974"><title>4. Material and Methods</title><sec id="sec4dot1-molecules-23-02974"><title>4.1. Botanical Material</title><p>Leaves from the species <italic>C. matourensis</italic> were collected in March 2014 in the green area of the Adolpho Ducke botanical garden at the Amazonia Museum (MUSA) (3&#x000b0;01&#x02032;12.8&#x02033; S, 59&#x000b0;56&#x02032;23.2&#x02033; W) from a specimen previously identified by N.M.D. Cardozo and catalogued (#492).</p></sec><sec id="sec4dot2-molecules-23-02974"><title>4.2. Essential Oil Extraction</title><p>After collection, the aerial parts were directly extracted by hydrodistillation in a Clevenger-type apparatus. For this, 300 g of fresh and crushed material was extracted for a period of 4 h in 1000 mL of ultrapure water (18.2 M&#x003a9;). Then, the obtained oils were extracted with CH<sub>2</sub>Cl<sub>2</sub>, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and filtered through a nylon membrane (pore size 0.22 &#x003bc;m, Whatman, Maidstone, UK). The resulting EO were weighed in vials and stored at &#x02212;4 &#x000b0;C prior to chemical analysis.</p></sec><sec id="sec4dot3-molecules-23-02974"><title>4.3. Chemical Analysis</title><p>The qualitative analysis was performed by gas chromatography coupled to mass spectrometry (GC-MS) with an equipment model GCMS/QP2010 Plus (Shimadzu, Kyoto, Japan) using a selective detector and a capillary column Rtx-5 MS (30 m &#x000d7; 0.25 mm &#x000d7; 0.25, Restek). Helium was used as carrier gas with a flow of 1.02 mL/min. Injections (1 &#x003bc;L) were performed with EO solutions at 2 mg/mL in CH<sub>2</sub>Cl<sub>2</sub> using a split ratio of 1:50. The column temperature program was 60 to 280 &#x000b0;C with gradual increase of 3 &#x000b0;C/min. The temperatures of the injector and the ion source were 220 &#x000b0;C and 260 &#x000b0;C, respectively. Preliminary identifications of the constituents were performed based on comparison of experimental spectra with those stored in the Wiley 8th edition library (similarities &#x0003e; 90%). The confirmation of the identifications was performed by the calculation of the retention indexes (RI) according to the Van den Dool and Kratz equation [<xref rid="B33-molecules-23-02974" ref-type="bibr">33</xref>] in comparison to a homologous series of linear hydrocarbons (C7-C30). A semi-quantitative analysis was performed to obtain the relative amount of each component of the EO. For this procedure, a gas chromatography with flame ionization detection (GC-FID) system, model GC2010 (Shimadzu) equipped with a Rtx-5 capillary column, was used. The same conditions of the GC-MS analysis were employed to ensure reproducibility. Relative amounts (%) were calculated in relation to the total area of the chromatogram.</p></sec><sec id="sec4dot4-molecules-23-02974"><title>4.4. In Vitro Assays</title><sec id="sec4dot4dot1-molecules-23-02974"><title>4.4.1. Cells</title><p>Human cancer cell lines MCF-7 (breast adenocarcinoma), HCT116 (colon carcinoma), HepG2 (hepatocellular carcinoma), HL-60 (promyelocytic leukemia), and human non-cancer cell line MRC-5 (lung fibroblast) were obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA). The cells were cultured as recommended by the ATCC. Cell viability was examined via trypan blue exclusion method for all experiments.</p></sec><sec id="sec4dot4dot2-molecules-23-02974"><title>4.4.2. Cell Viability Assay</title><p>Cell viability was measured by the Alamar blue assay and was performed as previously described [<xref rid="B34-molecules-23-02974" ref-type="bibr">34</xref>,<xref rid="B35-molecules-23-02974" ref-type="bibr">35</xref>,<xref rid="B36-molecules-23-02974" ref-type="bibr">36</xref>]. For all experiments, cells were plated in 96-well plates. The EO was dissolved in dimethyl sulfoxide (DMSO, Vetec Qu&#x000ed;mica Fina Ltd., Duque de Caxias, RJ, Brazil) and added to each well and incubated for 72 h. Doxorubicin (purity &#x02265; 95%, doxorubicin hydrochloride, Laboratory IMA S.A.I.C., Buenos Aires, Argentina) was used as the positive control. At the end of the treatment, 20 &#x003bc;L of a stock solution (0.312 mg/mL) of resazurin (Sigma-Aldrich Co., Saint Louis, MO, USA) was added to each well. Absorbances at 570 and 600 nm were measured using a SpectraMax 190 Microplate Reader (Molecular Devices, Sunnyvale, CA, USA).</p></sec><sec id="sec4dot4dot3-molecules-23-02974"><title>4.4.3. Annexin-V/PI Staining Assay</title><p>For apoptosis quantification, FITC Annexin V Apoptosis Detection Kit I (BD Biosciences, San Jose, CA, USA) was used, and the analysis performed according to the manufacturer&#x02019;s instructions. Cell fluorescence was measured by flow cytometry with a BD LSRFortessa cytometer. For flow cytometry analyses, 10<sup>4</sup> events were recorded per sample with the BD FACSDiva Software (BD Biosciences) and Flowjo Software 10 (Flowjo LLC, Ashland, OR, USA). Cellular debris was omitted from the analysis.</p></sec><sec id="sec4dot4dot4-molecules-23-02974"><title>4.4.4. Internucleosomal DNA Fragmentation and Cell Cycle Distribution</title><p>The internucleosomal DNA fragmentation and cell cycle distributions were determined using propidium iodide (PI) (Sigma-Aldrich Co. St. Louis, MO, USA) in permeabilized cells, and performed as previously described [<xref rid="B37-molecules-23-02974" ref-type="bibr">37</xref>]. Cell fluorescences were measured by flow cytometry as described above.</p></sec></sec><sec id="sec4dot5-molecules-23-02974"><title>4.5. In Vivo Assays</title><sec id="sec4dot5dot1-molecules-23-02974"><title>4.5.1. Animals</title><p>A total of 50 C.B<italic>-</italic>17 severe combined <italic/>immunodeficient (SCID) mice (females, 25&#x02013;30 g) were obtained and maintained at Gon&#x000e7;alo Moniz Institute-FIOCRUZ animal facilities (Salvador, Bahia, Brazil). Animals were housed in cages with free access to food and water. All animals were subjected to a 12:12 h light-dark cycle (lights on at 6:00 a.m.). A local animal ethics committee approved the experimental protocol employed (number #06/2015).</p></sec><sec id="sec4dot5dot2-molecules-23-02974"><title>4.5.2. Human Hepatocellular Carcinoma Xenograft Model</title><p>HepG2 cells (10<sup>7</sup> cells per 500 &#x000b5;L) were implanted subcutaneously into the left front armpits of the mice. At the beginning of the experiment, mice were randomly divided into four groups. Group 1: animals received injections of vehicle with 5% DMSO solution (<italic>n</italic> = 20). Group 2: animals received injections of 5-fluorouracil (10 mg/kg/day, Sigma-Aldrich, <italic>n</italic> = 10). Group 3: animals received injections of the EO at 40 mg/kg/day (<italic>n</italic> = 10). Group 4: animals received injections of the EO at 80 mg/kg/day (<italic>n</italic> = 10). These dosages were selected based on previous works using EO in tumor models in mice [<xref rid="B25-molecules-23-02974" ref-type="bibr">25</xref>,<xref rid="B38-molecules-23-02974" ref-type="bibr">38</xref>]. Beginning 1 day after tumor implantation, the animals were treated through the intraperitoneal route for 21 consecutive days. One day after the end of the treatment, animals were anesthetized, and peripheral blood samples were collected from the brachial artery. Animals were euthanized by anesthetic overdose, and tumors were excised and weighed.</p></sec><sec id="sec4dot5dot3-molecules-23-02974"><title>4.5.3. Toxicological Evaluation</title><p>The mice were weighed at the beginning and end of the experiment to evaluate the toxicological effects. Animals were observed for signs of abnormality throughout the study. A hematological analysis was performed using the Advia 60 hematology system (Bayer, Leverkusen, Germany). Livers, kidneys, lungs, and hearts were removed, weighed, and examined for signs of gross lesion formation, color change, and/or hemorrhaging.</p></sec></sec><sec id="sec4dot6-molecules-23-02974"><title>4.6. Statistical Analysis</title><p>Data were presented as means &#x000b1; standard error of the mean (SEM) or as IC<sub>50</sub> values with 95% confidence intervals obtained by nonlinear regressions. Differences among the experimental groups were compared through analysis of variance (ANOVA) followed by Bonferroni&#x02019;s multiple comparison test (<italic>P</italic> &#x0003c; 0.05). All statistical analyses were performed using GraphPad Prism (Intuitive Software for Science; San Diego, CA, USA).</p></sec></sec></body><back><ack><title>Acknowledgments</title><p>The authors are grateful to the flow cytometry core of FIOCRUZ-Bahia for collecting the flow cytometric data. This work was financially supported by Brazilian agencies Coordena&#x000e7;&#x000e3;o de Aperfei&#x000e7;oamento de Pessoal de N&#x000ed;vel Superior (CAPES), Conselho Nacional de Desenvolvimento Cient&#x000ed;fico e Tecnol&#x000f3;gico (CNPq), Funda&#x000e7;&#x000e3;o de Amparo &#x000e0; Pesquisa do Estado do Amazonas (FAPEAM), and Funda&#x000e7;&#x000e3;o de Amparo &#x000e0; Pesquisa do Estado da Bahia (FAPESB).</p></ack><fn-group><fn><p><bold>Sample Availability:</bold> Sample of the EO is not available from the authors.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceived and designed the experiments: H.H.F.K. and D.P.B. Collected the plant material and performed the chemical experiments: E.J.S.P.d.L., G.M.A.D., N.M.D.C., E.V.C., F.M.A.d.S., and H.H.F.K. Performed the in vitro and in vivo experiments: R.G.A., T.A.d.A., V.R.S., and L.d.S.S. Analyzed the data: J.S.P.L., G.M.A.D., N.M.D.C., E.V.C., F.M.A.d.S., H.H.F.K., R.G.A., T.A.d.A., V.R.S., L.d.S.S., M.B.P.S., and D.P.B. Contributed reagents/materials/analysis tools: M.B.P.S., H.H.F.K., and D.P.B. Wrote the paper: H.H.F.K. and D.P.B.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors have no conflicts of interest to declare.</p></notes><ref-list><title>References</title><ref id="B1-molecules-23-02974"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>W.H.</given-names></name><name><surname>Liu</surname><given-names>W.Y.</given-names></name><name><surname>Liang</surname><given-names>Q.</given-names></name></person-group><article-title>Chemical constituents from <italic>Croton</italic> species and their biological activities</article-title><source>Molecules</source><year>2018</year><volume>23</volume><pub-id pub-id-type="doi">10.3390/molecules23092333</pub-id><?supplied-pmid 30213129?><pub-id pub-id-type="pmid">30213129</pub-id></element-citation></ref><ref id="B2-molecules-23-02974"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Itokawa</surname><given-names>H.</given-names></name><name><surname>Ichihara</surname><given-names>Y.</given-names></name><name><surname>Mochizuki</surname><given-names>M.</given-names></name><name><surname>Enomori</surname><given-names>T.</given-names></name><name><surname>Morita</surname><given-names>H.</given-names></name><name><surname>Shirota</surname><given-names>O.</given-names></name><name><surname>Inamatsu</surname><given-names>M.</given-names></name><name><surname>Takeya</surname><given-names>K.</given-names></name></person-group><article-title>A cytotoxic substance from Sangre de Grado</article-title><source>Chem. Pharm. Bull.</source><year>1991</year><volume>39</volume><fpage>1041</fpage><lpage>1042</lpage><pub-id pub-id-type="doi">10.1248/cpb.39.1041</pub-id><?supplied-pmid 1893488?><pub-id pub-id-type="pmid">1893488</pub-id></element-citation></ref><ref id="B3-molecules-23-02974"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandoval</surname><given-names>M.</given-names></name><name><surname>Okuhama</surname><given-names>N.N.</given-names></name><name><surname>Clark</surname><given-names>M.</given-names></name><name><surname>Angeles</surname><given-names>F.M.</given-names></name><name><surname>Lao</surname><given-names>J.</given-names></name><name><surname>Bustamante</surname><given-names>S.</given-names></name><name><surname>Miller</surname><given-names>M.J.</given-names></name></person-group><article-title>Sangre de grado <italic>Croton palanostigma</italic> induces apoptosis in human gastrointestinal cancer cells</article-title><source>J. Ethnopharmacol.</source><year>2002</year><volume>80</volume><fpage>121</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1016/S0378-8741(02)00013-2</pub-id><pub-id pub-id-type="pmid">12007701</pub-id></element-citation></ref><ref id="B4-molecules-23-02974"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Z.P.</given-names></name><name><surname>Cai</surname><given-names>Y.</given-names></name><name><surname>Phillipson</surname><given-names>J.D.</given-names></name></person-group><article-title>Studies on the anti-tumour, anti-bacterial, and wound-healing properties of dragon&#x02019;s blood</article-title><source>Planta Med.</source><year>1994</year><volume>60</volume><fpage>541</fpage><lpage>545</lpage><pub-id pub-id-type="doi">10.1055/s-2006-959567</pub-id><?supplied-pmid 7809208?><pub-id pub-id-type="pmid">7809208</pub-id></element-citation></ref><ref id="B5-molecules-23-02974"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kupchan</surname><given-names>S.M.</given-names></name><name><surname>Uchida</surname><given-names>I.</given-names></name><name><surname>Branfman</surname><given-names>A.R.</given-names></name><name><surname>Dailey</surname><given-names>R.G.</given-names></name><name><surname>Fei</surname><given-names>B.Y.</given-names></name></person-group><article-title>Antileukemic principles isolated from euphorbiaceae plants</article-title><source>Science</source><year>1976</year><volume>191</volume><fpage>571</fpage><lpage>572</lpage><pub-id pub-id-type="doi">10.1126/science.1251193</pub-id><?supplied-pmid 1251193?><pub-id pub-id-type="pmid">1251193</pub-id></element-citation></ref><ref id="B6-molecules-23-02974"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bezerra</surname><given-names>D.P.</given-names></name><name><surname>Marinho-Filho</surname><given-names>J.D.</given-names></name><name><surname>Alves</surname><given-names>A.P.</given-names></name><name><surname>Pessoa</surname><given-names>C.</given-names></name><name><surname>Moraes</surname><given-names>M.O.</given-names></name><name><surname>Pessoa</surname><given-names>O.D.</given-names></name><name><surname>Torres</surname><given-names>M.C.</given-names></name><name><surname>Silveira</surname><given-names>E.R.</given-names></name><name><surname>Viana</surname><given-names>F.A.</given-names></name><name><surname>Costa-Lotufo</surname><given-names>L.V.</given-names></name></person-group><article-title>Antitumor activity of the essential oil from the leaves of <italic>Croton regelianus</italic> and its component ascaridole</article-title><source>Chem. Biodivers.</source><year>2009</year><volume>6</volume><fpage>1224</fpage><lpage>1231</lpage><pub-id pub-id-type="doi">10.1002/cbdv.200800253</pub-id><?supplied-pmid 19697341?><pub-id pub-id-type="pmid">19697341</pub-id></element-citation></ref><ref id="B7-molecules-23-02974"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alonso-Castro</surname><given-names>A.J.</given-names></name><name><surname>Ortiz-S&#x000e1;nchez</surname><given-names>E.</given-names></name><name><surname>Dom&#x000ed;nguez</surname><given-names>F.</given-names></name><name><surname>L&#x000f3;pez-Toledo</surname><given-names>G.</given-names></name><name><surname>Ch&#x000e1;vez</surname><given-names>M.</given-names></name><name><surname>Ortiz-Tello</surname><given-names>A.J.</given-names></name><name><surname>Garc&#x000ed;a-Carranc&#x000e1;</surname><given-names>A.</given-names></name></person-group><article-title>Antitumor effect of <italic>Croton lechleri</italic> Mull. Arg. (Euphorbiaceae)</article-title><source>J. Ethnopharmacol.</source><year>2012</year><volume>140</volume><fpage>438</fpage><lpage>442</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2012.01.009</pub-id><?supplied-pmid 22301443?><pub-id pub-id-type="pmid">22301443</pub-id></element-citation></ref><ref id="B8-molecules-23-02974"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>C&#x000e2;ndido-Bacani</surname><given-names>P.M.</given-names></name><name><surname>Figueiredo</surname><given-names>P.O.</given-names></name><name><surname>Matos</surname><given-names>M.F.</given-names></name><name><surname>Garcez</surname><given-names>F.R.</given-names></name><name><surname>Garcez</surname><given-names>W.S.</given-names></name></person-group><article-title>Cytotoxic orbitide from the latex of <italic>Croton urucurana</italic></article-title><source>J. Nat. Prod.</source><year>2015</year><volume>78</volume><fpage>2754</fpage><lpage>2760</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.5b00724</pub-id><?supplied-pmid 26561866?><pub-id pub-id-type="pmid">26561866</pub-id></element-citation></ref><ref id="B9-molecules-23-02974"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coelho</surname><given-names>P.L.</given-names></name><name><surname>Oliveira</surname><given-names>M.N.</given-names></name><name><surname>Silva</surname><given-names>A.B.</given-names></name><name><surname>Pitanga</surname><given-names>B.P.</given-names></name><name><surname>Silva</surname><given-names>V.D.</given-names></name><name><surname>Faria</surname><given-names>G.P.</given-names></name><name><surname>Sampaio</surname><given-names>G.P.</given-names></name><name><surname>Costa</surname><given-names>M.F.</given-names></name><name><surname>Braga-de-Souza</surname><given-names>S.</given-names></name><name><surname>Costa</surname><given-names>S.L.</given-names></name></person-group><article-title>The flavonoid apigenin from <italic>Croton betulaster</italic> Mull inhibits proliferation, induces differentiation and regulates the inflammatory profile of glioma cells</article-title><source>Anticancer Drugs</source><year>2016</year><volume>27</volume><fpage>960</fpage><lpage>969</lpage><pub-id pub-id-type="doi">10.1097/CAD.0000000000000413</pub-id><?supplied-pmid 27622606?><pub-id pub-id-type="pmid">27622606</pub-id></element-citation></ref><ref id="B10-molecules-23-02974"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>Q.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Tang</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Ke</surname><given-names>C.</given-names></name><name><surname>Ye</surname><given-names>Y.</given-names></name></person-group><article-title>Isolation and structure characterization of cytotoxic phorbol esters from the seeds of <italic>Croton tiglium</italic></article-title><source>Planta Med.</source><year>2017</year><volume>83</volume><fpage>1361</fpage><lpage>1367</lpage><pub-id pub-id-type="doi">10.1055/s-0043-110227</pub-id><?supplied-pmid 28499304?><pub-id pub-id-type="pmid">28499304</pub-id></element-citation></ref><ref id="B11-molecules-23-02974"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>Q.Q.</given-names></name><name><surname>Tang</surname><given-names>S.</given-names></name><name><surname>Song</surname><given-names>W.B.</given-names></name><name><surname>Wang</surname><given-names>W.Q.</given-names></name><name><surname>Huang</surname><given-names>M.</given-names></name><name><surname>Xuan</surname><given-names>L.J.</given-names></name></person-group><article-title>Crassins A-H, diterpenoids from the roots of <italic>Croton crassifolius</italic></article-title><source>J. Nat. Prod.</source><year>2017</year><volume>80</volume><fpage>254</fpage><lpage>260</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.6b00425</pub-id><?supplied-pmid 28150949?><pub-id pub-id-type="pmid">28150949</pub-id></element-citation></ref><ref id="B12-molecules-23-02974"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>J.R.</given-names></name><name><surname>Mitja</surname><given-names>D.</given-names></name></person-group><article-title>Use of vegetal resources by family farmers in Manacapuru, Amazonas state</article-title><source>Acta Amaz.</source><year>2010</year><volume>40</volume><fpage>49</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1590/S0044-59672010000100007</pub-id></element-citation></ref><ref id="B13-molecules-23-02974"><label>13.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Rodrigues</surname><given-names>L.</given-names></name></person-group><article-title>Inventory, Valorization of Forest Resources and Dynamics of Fragmentation in the Region of Influence of Juruena National Park, Mato Grosso</article-title><source>Ph.D. Thesis</source><publisher-name>Postgraduate Program in Ecology and Conservation, Universidade do Estado de Mato Grosso</publisher-name><publisher-loc>Nova Xavantina, Brazil</publisher-loc><year>2013</year><comment>(In Portuguese)</comment></element-citation></ref><ref id="B14-molecules-23-02974"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trindade</surname><given-names>M.J.S.</given-names></name><name><surname>Lameira</surname><given-names>O.A.</given-names></name></person-group><article-title>Species from the Euphorbiaceae family used for medicinal purposes in Brazil</article-title><source>Rev. Cubana Plan. Medicinales</source><year>2014</year><volume>19</volume><fpage>292</fpage><lpage>309</lpage></element-citation></ref><ref id="B15-molecules-23-02974"><label>15.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Cruz-Silva</surname><given-names>S.C.B.</given-names></name></person-group><article-title>Biodiversity History and Use in the Rural Black Community Quilombola Buriti Farm, Campo Grande, Mato Grosso Do Sul, Brazil</article-title><source>Ph.D. Thesis</source><publisher-name>Postgraduate Program in Environment and Regional Development, Universidade Anhanguera</publisher-name><publisher-loc>Campo Grande, MS, Brazil</publisher-loc><year>2016</year><comment>(In Portuguese)</comment></element-citation></ref><ref id="B16-molecules-23-02974"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gottlieb</surname><given-names>O.R.</given-names></name><name><surname>Koketsu</surname><given-names>M.</given-names></name><name><surname>Magalh&#x000e3;es</surname><given-names>M.T.</given-names></name><name><surname>Maia</surname><given-names>J.G.S.</given-names></name><name><surname>Mendes</surname><given-names>P.H.</given-names></name><name><surname>Rocha</surname><given-names>A.I.</given-names></name><name><surname>Silva</surname><given-names>M.L.</given-names></name><name><surname>Wiiberg</surname><given-names>V.C.</given-names></name></person-group><article-title>&#x000d3;leos essenciais da Amaz&#x000f4;nia VII</article-title><source>Acta Amaz.</source><year>1981</year><volume>11</volume><fpage>143</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1590/1809-43921981111143</pub-id></element-citation></ref><ref id="B17-molecules-23-02974"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le&#x000e3;o</surname><given-names>I.M.S.</given-names></name><name><surname>Andrade</surname><given-names>C.H.S.</given-names></name><name><surname>Pinheiro</surname><given-names>M.L.B.</given-names></name><name><surname>Rocha</surname><given-names>A.F.I.</given-names></name><name><surname>Machado</surname><given-names>M.I.L.</given-names></name><name><surname>Craveiro</surname><given-names>A.A.</given-names></name><name><surname>Alencar</surname><given-names>J.W.</given-names></name><name><surname>Matos</surname><given-names>F.J.A.</given-names></name></person-group><article-title>Essential oil of <italic>Croton lanjouwensis</italic> Jablonski from brazilian amazonian region</article-title><source>J. Essent. Oil Res.</source><year>1998</year><volume>10</volume><fpage>643</fpage><lpage>644</lpage><pub-id pub-id-type="doi">10.1080/10412905.1998.9700995</pub-id></element-citation></ref><ref id="B18-molecules-23-02974"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>C.</given-names></name><name><surname>Breitmaier</surname><given-names>E.</given-names></name><name><surname>Bayma</surname><given-names>J.</given-names></name><name><surname>Franca</surname><given-names>L.F.</given-names></name><name><surname>Kneifel</surname><given-names>H.</given-names></name><name><surname>Krebs</surname><given-names>H.C.</given-names></name></person-group><article-title>Maravuic acid, a new seco-labdane diterpene from <italic>Croton matourensis</italic></article-title><source>Liebigs Ann.</source><year>1995</year><fpage>709</fpage><lpage>710</lpage><pub-id pub-id-type="doi">10.1002/jlac.1995199504103</pub-id></element-citation></ref><ref id="B19-molecules-23-02974"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Compagnone</surname><given-names>R.S.</given-names></name><name><surname>Chavez</surname><given-names>K.</given-names></name><name><surname>Mateu</surname><given-names>E.</given-names></name><name><surname>Orsini</surname><given-names>G.</given-names></name><name><surname>Arvelo</surname><given-names>F.</given-names></name><name><surname>Su&#x000e1;rez</surname><given-names>A.I.</given-names></name></person-group><article-title>Composition and cytotoxic activity of essential oils from <italic>Croton matourensis</italic> and <italic>Croton micans</italic> from Venezuela</article-title><source>Rec. Nat. Prod.</source><year>2010</year><volume>4</volume><fpage>101</fpage><lpage>108</lpage></element-citation></ref><ref id="B20-molecules-23-02974"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>T.B.</given-names></name><name><surname>Costa</surname><given-names>C.O.</given-names></name><name><surname>Galv&#x000e3;o</surname><given-names>A.F.</given-names></name><name><surname>Bomfim</surname><given-names>L.M.</given-names></name><name><surname>Rodrigues</surname><given-names>A.C.</given-names></name><name><surname>Mota</surname><given-names>M.C.</given-names></name><name><surname>Dantas</surname><given-names>A.A.</given-names></name><name><surname>Santos</surname><given-names>T.R.</given-names></name><name><surname>Soares</surname><given-names>M.B.</given-names></name><name><surname>Bezerra</surname><given-names>D.P.</given-names></name></person-group><article-title>Cytotoxic potential of selected medicinal plants in northeast Brazil</article-title><source>BMC Complement. Altern. Med.</source><year>2016</year><volume>16</volume><elocation-id>199</elocation-id><pub-id pub-id-type="doi">10.1186/s12906-016-1166-1</pub-id><?supplied-pmid 27391476?><pub-id pub-id-type="pmid">27391476</pub-id></element-citation></ref><ref id="B21-molecules-23-02974"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bomfim</surname><given-names>L.M.</given-names></name><name><surname>Menezes</surname><given-names>L.R.</given-names></name><name><surname>Rodrigues</surname><given-names>A.C.</given-names></name><name><surname>Dias</surname><given-names>R.B.</given-names></name><name><surname>Rocha</surname><given-names>C.A.</given-names></name><name><surname>Soares</surname><given-names>M.B.</given-names></name><name><surname>Neto</surname><given-names>A.F.</given-names></name><name><surname>Nascimento</surname><given-names>M.P.</given-names></name><name><surname>Campos</surname><given-names>A.F.</given-names></name><name><surname>Silva</surname><given-names>L.C.</given-names></name><etal/></person-group><article-title>Antitumour activity of the microencapsulation of <italic>Annona vepretorum</italic> essential oil</article-title><source>Basic Clin. Pharmacol. Toxicol.</source><year>2016</year><volume>118</volume><fpage>208</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1111/bcpt.12488</pub-id><?supplied-pmid 26348780?><pub-id pub-id-type="pmid">26348780</pub-id></element-citation></ref><ref id="B22-molecules-23-02974"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>E.V.</given-names></name><name><surname>Menezes</surname><given-names>L.R.</given-names></name><name><surname>Rocha</surname><given-names>S.L.</given-names></name><name><surname>Baliza</surname><given-names>I.R.</given-names></name><name><surname>Dias</surname><given-names>R.B.</given-names></name><name><surname>Rocha</surname><given-names>C.A.</given-names></name><name><surname>Soares</surname><given-names>M.B.</given-names></name><name><surname>Bezerra</surname><given-names>D.P.</given-names></name></person-group><article-title>Antitumor properties of the leaf essential oil of <italic>Zornia brasiliensis</italic></article-title><source>Planta Med.</source><year>2015</year><volume>81</volume><fpage>563</fpage><lpage>567</lpage><pub-id pub-id-type="doi">10.1055/s-0035-1545842</pub-id><?supplied-pmid 25856436?><pub-id pub-id-type="pmid">25856436</pub-id></element-citation></ref><ref id="B23-molecules-23-02974"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sylvestre</surname><given-names>M.</given-names></name><name><surname>Pichette</surname><given-names>A.</given-names></name><name><surname>Longtin</surname><given-names>A.</given-names></name><name><surname>Nagau</surname><given-names>F.</given-names></name><name><surname>Legault</surname><given-names>J.</given-names></name></person-group><article-title>Essential oil analysis and anticancer activity of leaf essential oil of <italic>Croton flavens</italic> L. from Guadeloupe</article-title><source>J. Ethnopharmacol.</source><year>2006</year><volume>103</volume><fpage>99</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2005.07.011</pub-id><?supplied-pmid 16168586?><pub-id pub-id-type="pmid">16168586</pub-id></element-citation></ref><ref id="B24-molecules-23-02974"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monteiro</surname><given-names>P.A.</given-names></name><name><surname>Zelioli</surname><given-names>I.A.M.</given-names></name><name><surname>Sousa</surname><given-names>I.M.O.</given-names></name><name><surname>Ruiz</surname><given-names>A.L.T.G.</given-names></name><name><surname>Vendramini-Costa</surname><given-names>D.B.</given-names></name><name><surname>Foglio</surname><given-names>M.A.</given-names></name><name><surname>Carvalho</surname><given-names>J.E.</given-names></name></person-group><article-title>Chemical composition and antiproliferative activity of <italic>Croton campestris</italic> A.St.-Hil. essential oil</article-title><source>Nat. Prod. Res.</source><year>2017</year><volume>9</volume><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1080/14786419.2017.1399377</pub-id><?supplied-pmid 29117729?><pub-id pub-id-type="pmid">29117729</pub-id></element-citation></ref><ref id="B25-molecules-23-02974"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferraz</surname><given-names>R.P.</given-names></name><name><surname>Bomfim</surname><given-names>D.S.</given-names></name><name><surname>Carvalho</surname><given-names>N.C.</given-names></name><name><surname>Soares</surname><given-names>M.B.</given-names></name><name><surname>Silva</surname><given-names>T.B.</given-names></name><name><surname>Machado</surname><given-names>W.J.</given-names></name><name><surname>Prata</surname><given-names>A.P.</given-names></name><name><surname>Costa</surname><given-names>E.V.</given-names></name><name><surname>Moraes</surname><given-names>V.R.</given-names></name><name><surname>Nogueira</surname><given-names>P.C.</given-names></name><etal/></person-group><article-title>Cytotoxic effect of leaf essential oil of <italic>Lippia gracilis</italic> Schauer (Verbenaceae)</article-title><source>Phytomedicine</source><year>2013</year><volume>20</volume><fpage>615</fpage><lpage>621</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2013.01.015</pub-id><?supplied-pmid 23453306?><pub-id pub-id-type="pmid">23453306</pub-id></element-citation></ref><ref id="B26-molecules-23-02974"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Footy</surname><given-names>K.O.</given-names></name><name><surname>Alarif</surname><given-names>W.M.</given-names></name><name><surname>Zubair</surname><given-names>M.S.</given-names></name><name><surname>Ghandourah</surname><given-names>M.A.</given-names></name><name><surname>Aly</surname><given-names>M.M.</given-names></name></person-group><article-title>Antibacterial and cytotoxic properties of isoprenoids from the red sea soft coral, <italic>Lobophytum</italic> sp.</article-title><source>Trop. J. Pharm. Res.</source><year>2016</year><volume>15</volume><fpage>1431</fpage><lpage>1438</lpage><pub-id pub-id-type="doi">10.4314/tjpr.v15i7.11</pub-id></element-citation></ref><ref id="B27-molecules-23-02974"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fidyt</surname><given-names>K.</given-names></name><name><surname>Fiedorowicz</surname><given-names>A.</given-names></name><name><surname>Strz&#x00105;da&#x00142;a</surname><given-names>L.</given-names></name><name><surname>Szumny</surname><given-names>A.</given-names></name></person-group><article-title><italic>&#x003b2;</italic>-caryophyllene and <italic>&#x003b2;</italic>-caryophyllene oxide-natural compounds of anticancer and analgesic properties</article-title><source>Cancer Med.</source><year>2016</year><volume>5</volume><fpage>3007</fpage><lpage>3017</lpage><pub-id pub-id-type="doi">10.1002/cam4.816</pub-id><?supplied-pmid 27696789?><pub-id pub-id-type="pmid">27696789</pub-id></element-citation></ref><ref id="B28-molecules-23-02974"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Z.</given-names></name><name><surname>Jacob</surname><given-names>J.A.</given-names></name><name><surname>Loganathachetti</surname><given-names>D.S.</given-names></name><name><surname>Nainangu</surname><given-names>P.</given-names></name><name><surname>Chen</surname><given-names>B.</given-names></name></person-group><article-title><italic>&#x003b2;</italic>-Elemene: Mechanistic studies on cancer cell interaction and its chemosensitization effect</article-title><source>Front. Pharmacol.</source><year>2017</year><volume>8</volume><fpage>105</fpage><pub-id pub-id-type="doi">10.3389/fphar.2017.00105</pub-id><?supplied-pmid 28337141?><pub-id pub-id-type="pmid">28337141</pub-id></element-citation></ref><ref id="B29-molecules-23-02974"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galluzzi</surname><given-names>L.</given-names></name><name><surname>Vitale</surname><given-names>I.</given-names></name><name><surname>Aaronson</surname><given-names>S.A.</given-names></name><name><surname>Abrams</surname><given-names>J.M.</given-names></name><name><surname>Adam</surname><given-names>D.</given-names></name><name><surname>Agostinis</surname><given-names>P.</given-names></name><name><surname>Alnemri</surname><given-names>E.S.</given-names></name><name><surname>Altucci</surname><given-names>L.</given-names></name><name><surname>Amelio</surname><given-names>I.</given-names></name><name><surname>Andrews</surname><given-names>D.W.</given-names></name><etal/></person-group><article-title>Molecular mechanisms of cell death: Recommendations of the nomenclature committee on cell death 2018</article-title><source>Cell Death Differ.</source><year>2018</year><volume>25</volume><fpage>486</fpage><lpage>541</lpage><pub-id pub-id-type="doi">10.1038/s41418-017-0012-4</pub-id><?supplied-pmid 29362479?><pub-id pub-id-type="pmid">29362479</pub-id></element-citation></ref><ref id="B30-molecules-23-02974"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferraz</surname><given-names>R.P.C.</given-names></name><name><surname>Bomfim</surname><given-names>D.S.</given-names></name><name><surname>Carvalho</surname><given-names>N.C.</given-names></name><name><surname>Soares</surname><given-names>M.B.P.</given-names></name><name><surname>Pinheiro</surname><given-names>M.L.B.</given-names></name><name><surname>Costa</surname><given-names>E.V.</given-names></name><name><surname>Bezerra</surname><given-names>D.P.</given-names></name></person-group><article-title>Cytotoxic properties of the leaf essential oils of <italic>Guatteria blepharophylla</italic> and <italic>Guatteria hispida</italic> (Annonaceae)</article-title><source>Flavour Fragr J.</source><year>2014</year><volume>29</volume><fpage>228</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.1002/ffj.3199</pub-id></element-citation></ref><ref id="B31-molecules-23-02974"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russo</surname><given-names>A.</given-names></name><name><surname>Cardile</surname><given-names>V.</given-names></name><name><surname>Graziano</surname><given-names>A.C.E.</given-names></name><name><surname>Avola</surname><given-names>R.</given-names></name><name><surname>Bruno</surname><given-names>M.</given-names></name><name><surname>Rigano</surname><given-names>D.</given-names></name></person-group><article-title>Involvement of Bax and Bcl-2 in induction of apoptosis by essential oils of three Lebanese Salvia species in human prostate cancer cells</article-title><source>Int. J. Mol. Sci.</source><year>2018</year><volume>19</volume><elocation-id>E292</elocation-id><pub-id pub-id-type="doi">10.3390/ijms19010292</pub-id><?supplied-pmid 29351194?><pub-id pub-id-type="pmid">29351194</pub-id></element-citation></ref><ref id="B32-molecules-23-02974"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sajid</surname><given-names>A.</given-names></name><name><surname>Manzoor</surname><given-names>Q.</given-names></name><name><surname>Iqbal</surname><given-names>M.</given-names></name><name><surname>Tyagi</surname><given-names>A.K.</given-names></name><name><surname>Sarfraz</surname><given-names>R.A.</given-names></name><name><surname>Sajid</surname><given-names>A.</given-names></name></person-group><article-title><italic>Pinus Roxburghii</italic> essential oil anticancer activity and chemical composition evaluation</article-title><source>EXCLI J.</source><year>2018</year><volume>17</volume><fpage>233</fpage><lpage>245</lpage><?supplied-pmid 29743861?><pub-id pub-id-type="pmid">29743861</pub-id></element-citation></ref><ref id="B33-molecules-23-02974"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Den Dool</surname><given-names>H.</given-names></name><name><surname>Kratz</surname><given-names>P.D.</given-names></name></person-group><article-title>A generalization of the retention index system including linear temperature programmed gas-liquid partition chromatography</article-title><source>J. Chromatogr. A</source><year>1963</year><volume>11</volume><fpage>463</fpage><lpage>471</lpage><pub-id pub-id-type="doi">10.1016/S0021-9673(01)80947-X</pub-id></element-citation></ref><ref id="B34-molecules-23-02974"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>S.A.</given-names></name><name><surname>Gogal</surname><given-names>R.M.</given-names><suffix>Jr.</suffix></name><name><surname>Walsh</surname><given-names>J.E.</given-names></name></person-group><article-title>A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: An alternative to [<sup>3</sup>H]-thymidine incorporation assay</article-title><source>J. Immunol. Methods</source><year>1994</year><volume>170</volume><fpage>211</fpage><lpage>224</lpage><pub-id pub-id-type="doi">10.1016/0022-1759(94)90396-4</pub-id><pub-id pub-id-type="pmid">8157999</pub-id></element-citation></ref><ref id="B35-molecules-23-02974"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santos</surname><given-names>L.S.</given-names></name><name><surname>Silva</surname><given-names>V.R.</given-names></name><name><surname>Menezes</surname><given-names>L.R.A.</given-names></name><name><surname>Soares</surname><given-names>M.B.P.</given-names></name><name><surname>Costa</surname><given-names>E.V.</given-names></name><name><surname>Bezerra</surname><given-names>D.P.</given-names></name></person-group><article-title>Xylopine induces oxidative stress and causes G<sub>2</sub>/M phase arrest, triggering caspase-mediated apoptosis by p53-independent pathway in HCT116 cells</article-title><source>Oxid. Med. Cell. Longev.</source><year>2017</year><volume>2017</volume><fpage>7126872</fpage><pub-id pub-id-type="doi">10.1155/2017/7126872</pub-id><?supplied-pmid 29362667?><pub-id pub-id-type="pmid">29362667</pub-id></element-citation></ref><ref id="B36-molecules-23-02974"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>V.R.</given-names></name><name><surname>Corr&#x000ea;a</surname><given-names>R.S.</given-names></name><name><surname>Santos</surname><given-names>L.S.</given-names></name><name><surname>Soares</surname><given-names>M.B.P.</given-names></name><name><surname>Batista</surname><given-names>A.A.</given-names></name><name><surname>Bezerra</surname><given-names>D.P.</given-names></name></person-group><article-title>A ruthenium-based 5-fluorouracil complex with enhanced cytotoxicity and apoptosis induction action in HCT116 cells</article-title><source>Sci. Rep.</source><year>2018</year><volume>8</volume><fpage>288</fpage><pub-id pub-id-type="doi">10.1038/s41598-017-18639-6</pub-id><?supplied-pmid 29321581?><pub-id pub-id-type="pmid">29321581</pub-id></element-citation></ref><ref id="B37-molecules-23-02974"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicoletti</surname><given-names>I.</given-names></name><name><surname>Migliorati</surname><given-names>G.</given-names></name><name><surname>Pagliacci</surname><given-names>M.C.</given-names></name><name><surname>Grignani</surname><given-names>F.</given-names></name><name><surname>Riccardi</surname><given-names>C.</given-names></name></person-group><article-title>A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry</article-title><source>J. Immunol. Methods</source><year>1991</year><volume>139</volume><fpage>271</fpage><lpage>279</lpage><pub-id pub-id-type="doi">10.1016/0022-1759(91)90198-O</pub-id><pub-id pub-id-type="pmid">1710634</pub-id></element-citation></ref><ref id="B38-molecules-23-02974"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodrigues</surname><given-names>A.C.</given-names></name><name><surname>Bomfim</surname><given-names>L.M.</given-names></name><name><surname>Neves</surname><given-names>S.P.</given-names></name><name><surname>Menezes</surname><given-names>L.R.</given-names></name><name><surname>Dias</surname><given-names>R.B.</given-names></name><name><surname>Soares</surname><given-names>M.B.</given-names></name><name><surname>Prata</surname><given-names>A.P.</given-names></name><name><surname>Rocha</surname><given-names>C.A.</given-names></name><name><surname>Costa</surname><given-names>E.V.</given-names></name><name><surname>Bezerra</surname><given-names>D.P.</given-names></name></person-group><article-title>Antitumor properties of the essential oil from the leaves of <italic>Duguetia gardneriana</italic></article-title><source>Planta Med.</source><year>2015</year><volume>81</volume><fpage>798</fpage><lpage>803</lpage><pub-id pub-id-type="pmid">26125546</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="molecules-23-02974-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Effect of the essential oil (EO) from the leaves of <italic>Croton matourensis</italic> on the induction of apoptosis (early + late apoptotic cells) in HepG2 cells after 48 h of treatment, as determined by flow cytometry using annexin V-FITC/PI staining. The negative control (CTL) was treated with the vehicle (0.1% DMSO) used for diluting the EO. Doxorubicin (DOX, 1 &#x000b5;g/mL) was used as the positive control. Data are presented as the means &#x000b1; SEM. of three independent experiments performed in duplicate. Ten thousand events were evaluated per experiment, and cellular debris was omitted from the analysis. * <italic>P</italic> &#x0003c; 0.05 compared with the negative control by ANOVA, followed by Bonferroni&#x02019;s multiple comparison test.</p></caption><graphic xlink:href="molecules-23-02974-g001"/></fig><fig id="molecules-23-02974-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Effect of the essential oil (EO) from the leaves of <italic>Croton matourensis</italic> in the cell cycle distribution of HepG2 cells. (<bold>A</bold>) Percentage of cells with sub-G<sub>0</sub>/G<sub>1</sub> DNA content (DNA fragmentation). (<bold>B</bold>) Percentage of cells with G<sub>0</sub>/G<sub>1</sub> phase DNA content. (<bold>C</bold>) Percentage of cells with S phase DNA content. (<bold>D</bold>) Percentage of cells with G<sub>2</sub>/M phase DNA content. The negative control (CTL) was treated with the vehicle (0.1% DMSO) used for diluting the EO. Doxorubicin (DOX, 1 &#x000b5;g/mL) was used as the positive control. Data are presented as the means &#x000b1; SEM. of three independent experiments performed in duplicate. Ten thousand events were evaluated per experiment, and cellular debris was omitted from the analysis. * <italic>P</italic> &#x0003c; 0.05 compared with the negative control by ANOVA, followed by Bonferroni&#x02019;s multiple comparison test.</p></caption><graphic xlink:href="molecules-23-02974-g002"/></fig><fig id="molecules-23-02974-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>In vivo antitumor activity of the essential oil (EO) from the leaves of <italic>Croton matourensis</italic> in C.B-17 severe combined <italic/>immunodeficient (SCID) mice with HepG2 cell xenografts. (<bold>A</bold>) Tumor weight (g) after treatment. (<bold>B</bold>) Tumor inhibition (%) after treatment. Beginning 1 day after tumor implantation, the animals were treated through the intraperitoneal route for 21 consecutive days. The negative control (CTL) was treated with the vehicle (5% DMSO) used for diluting the EO. 5-Fluorouracil (5-FU, 10 mg/kg/day) was used as the positive control. Data are presented as means &#x000b1; SEM. of 10&#x02013;20 animals. * <italic>P</italic> &#x0003c; 0.05 compared to the negative control by ANOVA followed by Bonferroni&#x02019;s multiple comparison test.</p></caption><graphic xlink:href="molecules-23-02974-g003"/></fig><table-wrap id="molecules-23-02974-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-23-02974-t001_Table 1</object-id><label>Table 1</label><caption><p>Chemical composition of the essential oil from the leaves of <italic>Croton matourensis.</italic></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Number</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compound</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Retention Time (min)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">RI<break/>Theo. <sup>a</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">RI<break/>Exp. <sup>b</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Proportion<break/>Area (%) <sup>c</sup></th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b1;-thujene</td><td align="center" valign="middle" rowspan="1" colspan="1">5.28</td><td align="center" valign="middle" rowspan="1" colspan="1">924</td><td align="center" valign="middle" rowspan="1" colspan="1">924</td><td align="center" valign="middle" rowspan="1" colspan="1">1.99 &#x000b1; 0.21</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b1;-pinene</td><td align="center" valign="middle" rowspan="1" colspan="1">5.48</td><td align="center" valign="middle" rowspan="1" colspan="1">932</td><td align="center" valign="middle" rowspan="1" colspan="1">931</td><td align="center" valign="middle" rowspan="1" colspan="1">3.41 &#x000b1; 0.34</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">sabinene</td><td align="center" valign="middle" rowspan="1" colspan="1">6.60</td><td align="center" valign="middle" rowspan="1" colspan="1">969</td><td align="center" valign="middle" rowspan="1" colspan="1">969</td><td align="center" valign="middle" rowspan="1" colspan="1">0.11 &#x000b1; 0.03</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">4</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b2;-pinene</td><td align="center" valign="middle" rowspan="1" colspan="1">6.72</td><td align="center" valign="middle" rowspan="1" colspan="1">974</td><td align="center" valign="middle" rowspan="1" colspan="1">974</td><td align="center" valign="middle" rowspan="1" colspan="1">0.25 &#x000b1; 0.04</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">5</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b2;-myrcene</td><td align="center" valign="middle" rowspan="1" colspan="1">7.11</td><td align="center" valign="middle" rowspan="1" colspan="1">988</td><td align="center" valign="middle" rowspan="1" colspan="1">987</td><td align="center" valign="middle" rowspan="1" colspan="1">0.26 &#x000b1; 0.04</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b1;-phellandrene</td><td align="center" valign="middle" rowspan="1" colspan="1">7.59</td><td align="center" valign="middle" rowspan="1" colspan="1">1002</td><td align="center" valign="middle" rowspan="1" colspan="1">1002</td><td align="center" valign="middle" rowspan="1" colspan="1">3.90 &#x000b1; 0.28</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">7</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b1;-terpinene</td><td align="center" valign="middle" rowspan="1" colspan="1">8.02</td><td align="center" valign="middle" rowspan="1" colspan="1">1014</td><td align="center" valign="middle" rowspan="1" colspan="1">1014</td><td align="center" valign="middle" rowspan="1" colspan="1">0.54 &#x000b1; 0.30</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">8</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>p</italic>-cymene</td><td align="center" valign="middle" rowspan="1" colspan="1">8.31</td><td align="center" valign="middle" rowspan="1" colspan="1">1020</td><td align="center" valign="middle" rowspan="1" colspan="1">1020</td><td align="center" valign="middle" rowspan="1" colspan="1">5.05 &#x000b1; 0.49</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">9</td><td align="center" valign="middle" rowspan="1" colspan="1">limonene</td><td align="center" valign="middle" rowspan="1" colspan="1">8.46</td><td align="center" valign="middle" rowspan="1" colspan="1">1024</td><td align="center" valign="middle" rowspan="1" colspan="1">1023</td><td align="center" valign="middle" rowspan="1" colspan="1">1.85 &#x000b1; 0.18</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">10</td><td align="center" valign="middle" rowspan="1" colspan="1">eucalyptol</td><td align="center" valign="middle" rowspan="1" colspan="1">8.57</td><td align="center" valign="middle" rowspan="1" colspan="1">1026</td><td align="center" valign="middle" rowspan="1" colspan="1">1026</td><td align="center" valign="middle" rowspan="1" colspan="1">0.15 &#x000b1; 0.02</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">11</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b2;-ocimene</td><td align="center" valign="middle" rowspan="1" colspan="1">9.18</td><td align="center" valign="middle" rowspan="1" colspan="1">1032</td><td align="center" valign="middle" rowspan="1" colspan="1">1032</td><td align="center" valign="middle" rowspan="1" colspan="1">0.13 &#x000b1; 0.02</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">12</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b3;-terpinene</td><td align="center" valign="middle" rowspan="1" colspan="1">9.62</td><td align="center" valign="middle" rowspan="1" colspan="1">1054</td><td align="center" valign="middle" rowspan="1" colspan="1">1054</td><td align="center" valign="middle" rowspan="1" colspan="1">2.02 &#x000b1; 0.23</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">13</td><td align="center" valign="middle" rowspan="1" colspan="1">terpinolene</td><td align="center" valign="middle" rowspan="1" colspan="1">10.85</td><td align="center" valign="middle" rowspan="1" colspan="1">1086</td><td align="center" valign="middle" rowspan="1" colspan="1">1086</td><td align="center" valign="middle" rowspan="1" colspan="1">2.15 &#x000b1; 0.18</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">14</td><td align="center" valign="middle" rowspan="1" colspan="1">linalool</td><td align="center" valign="middle" rowspan="1" colspan="1">11.30</td><td align="center" valign="middle" rowspan="1" colspan="1">1095</td><td align="center" valign="middle" rowspan="1" colspan="1">1095</td><td align="center" valign="middle" rowspan="1" colspan="1">3.85 &#x000b1; 0.34</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">15</td><td align="center" valign="middle" rowspan="1" colspan="1">4-terpineol</td><td align="center" valign="middle" rowspan="1" colspan="1">14.87</td><td align="center" valign="middle" rowspan="1" colspan="1">1130</td><td align="center" valign="middle" rowspan="1" colspan="1">1130</td><td align="center" valign="middle" rowspan="1" colspan="1">0.25 &#x000b1; 0.05</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">16</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b1;-terpineol</td><td align="center" valign="middle" rowspan="1" colspan="1">15.52</td><td align="center" valign="middle" rowspan="1" colspan="1">1131</td><td align="center" valign="middle" rowspan="1" colspan="1">1131</td><td align="center" valign="middle" rowspan="1" colspan="1">0.21 &#x000b1; 0.04</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">17</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b1;-copaene</td><td align="center" valign="middle" rowspan="1" colspan="1">24.62</td><td align="center" valign="middle" rowspan="1" colspan="1">1374</td><td align="center" valign="middle" rowspan="1" colspan="1">1373</td><td align="center" valign="middle" rowspan="1" colspan="1">1.92 &#x000b1; 0.15</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">18</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b1;-bourbonene</td><td align="center" valign="middle" rowspan="1" colspan="1">25.06</td><td align="center" valign="middle" rowspan="1" colspan="1">1387</td><td align="center" valign="middle" rowspan="1" colspan="1">1387</td><td align="center" valign="middle" rowspan="1" colspan="1">0.36 &#x000b1; 0.05</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">19</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b2;-elemene</td><td align="center" valign="middle" rowspan="1" colspan="1">25.48</td><td align="center" valign="middle" rowspan="1" colspan="1">1389</td><td align="center" valign="middle" rowspan="1" colspan="1">1388</td><td align="center" valign="middle" rowspan="1" colspan="1">4.94 &#x000b1; 0.35</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">20</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b2;-caryophyllene</td><td align="center" valign="middle" rowspan="1" colspan="1">26.74</td><td align="center" valign="middle" rowspan="1" colspan="1">1417</td><td align="center" valign="middle" rowspan="1" colspan="1">1417</td><td align="center" valign="middle" rowspan="1" colspan="1">12.41 &#x000b1; 1.02</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">21</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b1;-humulene</td><td align="center" valign="middle" rowspan="1" colspan="1">28.36</td><td align="center" valign="middle" rowspan="1" colspan="1">1436</td><td align="center" valign="middle" rowspan="1" colspan="1">1436</td><td align="center" valign="middle" rowspan="1" colspan="1">2.52 &#x000b1; 0.20</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">22</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b2;-farnesene</td><td align="center" valign="middle" rowspan="1" colspan="1">28.62</td><td align="center" valign="middle" rowspan="1" colspan="1">1440</td><td align="center" valign="middle" rowspan="1" colspan="1">1440</td><td align="center" valign="middle" rowspan="1" colspan="1">2.33 &#x000b1; 0.14</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">23</td><td align="center" valign="middle" rowspan="1" colspan="1">aromadendrane</td><td align="center" valign="middle" rowspan="1" colspan="1">28.72</td><td align="center" valign="middle" rowspan="1" colspan="1">1460</td><td align="center" valign="middle" rowspan="1" colspan="1">1559</td><td align="center" valign="middle" rowspan="1" colspan="1">0.64 &#x000b1; 0.11</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">24</td><td align="center" valign="middle" rowspan="1" colspan="1">germacrene B</td><td align="center" valign="middle" rowspan="1" colspan="1">29.52</td><td align="center" valign="middle" rowspan="1" colspan="1">1480</td><td align="center" valign="middle" rowspan="1" colspan="1">1480</td><td align="center" valign="middle" rowspan="1" colspan="1">1.07 &#x000b1; 0.29</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">25</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b1;-amorphene</td><td align="center" valign="middle" rowspan="1" colspan="1">29.71</td><td align="center" valign="middle" rowspan="1" colspan="1">1483</td><td align="center" valign="middle" rowspan="1" colspan="1">1483</td><td align="center" valign="middle" rowspan="1" colspan="1">0.90 &#x000b1; 0.13</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">26</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b1;-selinene</td><td align="center" valign="middle" rowspan="1" colspan="1">30.37</td><td align="center" valign="middle" rowspan="1" colspan="1">1498</td><td align="center" valign="middle" rowspan="1" colspan="1">1498</td><td align="center" valign="middle" rowspan="1" colspan="1">0.95 &#x000b1; 0.08</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">27</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b2;-bisabolene</td><td align="center" valign="middle" rowspan="1" colspan="1">31.06</td><td align="center" valign="middle" rowspan="1" colspan="1">1505</td><td align="center" valign="middle" rowspan="1" colspan="1">1505</td><td align="center" valign="middle" rowspan="1" colspan="1">0.59 &#x000b1; 0.05</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">28</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b3;-cadinene</td><td align="center" valign="middle" rowspan="1" colspan="1">31.74</td><td align="center" valign="middle" rowspan="1" colspan="1">1513</td><td align="center" valign="middle" rowspan="1" colspan="1">1513</td><td align="center" valign="middle" rowspan="1" colspan="1">0.99 &#x000b1; 0.11</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">29</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b1;-elemol</td><td align="center" valign="middle" rowspan="1" colspan="1">32.91</td><td align="center" valign="middle" rowspan="1" colspan="1">1548</td><td align="center" valign="middle" rowspan="1" colspan="1">1548</td><td align="center" valign="middle" rowspan="1" colspan="1">0.96 &#x000b1; 0.09</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">30</td><td align="center" valign="middle" rowspan="1" colspan="1">spathulenol</td><td align="center" valign="middle" rowspan="1" colspan="1">34.18</td><td align="center" valign="middle" rowspan="1" colspan="1">1577</td><td align="center" valign="middle" rowspan="1" colspan="1">1577</td><td align="center" valign="middle" rowspan="1" colspan="1">1.29 &#x000b1; 0.15</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">31</td><td align="center" valign="middle" rowspan="1" colspan="1">caryophyllene oxide</td><td align="center" valign="middle" rowspan="1" colspan="1">34.41</td><td align="center" valign="middle" rowspan="1" colspan="1">1582</td><td align="center" valign="middle" rowspan="1" colspan="1">1582</td><td align="center" valign="middle" rowspan="1" colspan="1">3.19 &#x000b1; 0.31</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">32</td><td align="center" valign="middle" rowspan="1" colspan="1">globulol</td><td align="center" valign="middle" rowspan="1" colspan="1">34.81</td><td align="center" valign="middle" rowspan="1" colspan="1">1590</td><td align="center" valign="middle" rowspan="1" colspan="1">1590</td><td align="center" valign="middle" rowspan="1" colspan="1">0.65 &#x000b1; 0.12</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">33</td><td align="center" valign="middle" rowspan="1" colspan="1">viridiflorol</td><td align="center" valign="middle" rowspan="1" colspan="1">35.33</td><td align="center" valign="middle" rowspan="1" colspan="1">1592</td><td align="center" valign="middle" rowspan="1" colspan="1">1592</td><td align="center" valign="middle" rowspan="1" colspan="1">0.24 &#x000b1; 0.07</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">34</td><td align="center" valign="middle" rowspan="1" colspan="1">salvial-4(14)-en-1-one</td><td align="center" valign="middle" rowspan="1" colspan="1">35.60</td><td align="center" valign="middle" rowspan="1" colspan="1">1593</td><td align="center" valign="middle" rowspan="1" colspan="1">1593</td><td align="center" valign="middle" rowspan="1" colspan="1">0.34 &#x000b1; 0.09</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">35</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b1;-cadinol</td><td align="center" valign="middle" rowspan="1" colspan="1">37.30</td><td align="center" valign="middle" rowspan="1" colspan="1">1638</td><td align="center" valign="middle" rowspan="1" colspan="1">1638</td><td align="center" valign="middle" rowspan="1" colspan="1">0.38 &#x000b1; 0.08</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">36</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x003c4;-muurolol</td><td align="center" valign="middle" rowspan="1" colspan="1">37.41</td><td align="center" valign="middle" rowspan="1" colspan="1">1643</td><td align="center" valign="middle" rowspan="1" colspan="1">1643</td><td align="center" valign="middle" rowspan="1" colspan="1">0.48 &#x000b1; 0.10</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">37</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b2;-eudesmol</td><td align="center" valign="middle" rowspan="1" colspan="1">37.55</td><td align="center" valign="middle" rowspan="1" colspan="1">1649</td><td align="center" valign="middle" rowspan="1" colspan="1">1649</td><td align="center" valign="middle" rowspan="1" colspan="1">0.52 &#x000b1; 0.13</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">38</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b1;-eudesmol</td><td align="center" valign="middle" rowspan="1" colspan="1">37.61</td><td align="center" valign="middle" rowspan="1" colspan="1">1652</td><td align="center" valign="middle" rowspan="1" colspan="1">1652</td><td align="center" valign="middle" rowspan="1" colspan="1">0.48 &#x000b1; 0.11</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">39</td><td align="center" valign="middle" rowspan="1" colspan="1">bulnesol</td><td align="center" valign="middle" rowspan="1" colspan="1">48.93</td><td align="center" valign="middle" rowspan="1" colspan="1">1670</td><td align="center" valign="middle" rowspan="1" colspan="1">1670</td><td align="center" valign="middle" rowspan="1" colspan="1">4.37 &#x000b1; 0.48</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">40</td><td align="center" valign="middle" rowspan="1" colspan="1">cembrene</td><td align="center" valign="middle" rowspan="1" colspan="1">53.40</td><td align="center" valign="middle" rowspan="1" colspan="1">1937</td><td align="center" valign="middle" rowspan="1" colspan="1">1938</td><td align="center" valign="middle" rowspan="1" colspan="1">7.12 &#x000b1; 0.55</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">41</td><td align="center" valign="middle" rowspan="1" colspan="1">thunbergol</td><td align="center" valign="middle" rowspan="1" colspan="1">56.69</td><td align="center" valign="middle" rowspan="1" colspan="1">2061</td><td align="center" valign="middle" rowspan="1" colspan="1">2063</td><td align="center" valign="middle" rowspan="1" colspan="1">11.74 &#x000b1; 1.11</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">42</td><td align="center" valign="middle" rowspan="1" colspan="1">geranyllinalool</td><td align="center" valign="middle" rowspan="1" colspan="1">56.90</td><td align="center" valign="middle" rowspan="1" colspan="1">2125</td><td align="center" valign="middle" rowspan="1" colspan="1">2125</td><td align="center" valign="middle" rowspan="1" colspan="1">2.30 &#x000b1; 0.34</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<sub>&#x003a3;total identified</sub>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">90.00%</td></tr></tbody></table><table-wrap-foot><fn><p><sup>a</sup> Retention indexes (RI) calculated with the Van den Dool and Kratz equation, <sup>b</sup> Main observed fragments and molecular mass (MM), <sup>c</sup> Proportional area relative to the total area of chromatogram after eliminating peaks arising of contamination and/or column bleeding.</p></fn></table-wrap-foot></table-wrap><table-wrap id="molecules-23-02974-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-23-02974-t002_Table 2</object-id><label>Table 2</label><caption><p>Half maximal inhibitory concentration (IC<sub>50</sub>) values of the cytotoxic activity of the essential oil (EO) from the leaves of <italic>Croton matourensis.</italic></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cell Lines</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Origin</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Histological Type</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">IC<sub>50</sub> in &#x000b5;g/mL</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EO</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DOX</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Cancer cells</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MCF-7</td><td align="center" valign="middle" rowspan="1" colspan="1">Human</td><td align="center" valign="middle" rowspan="1" colspan="1">Breast adenocarcinoma</td><td align="center" valign="middle" rowspan="1" colspan="1">23.3 <break/>18.2&#x02013;29.7</td><td align="center" valign="middle" rowspan="1" colspan="1">0.3 <break/>0.2&#x02013;0.4</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">HCT116</td><td align="center" valign="middle" rowspan="1" colspan="1">Human</td><td align="center" valign="middle" rowspan="1" colspan="1">Colon carcinoma</td><td align="center" valign="middle" rowspan="1" colspan="1">28.9 <break/>22.1&#x02013;37.8</td><td align="center" valign="middle" rowspan="1" colspan="1">0.1 <break/>0.1&#x02013;0.2</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">HepG2</td><td align="center" valign="middle" rowspan="1" colspan="1">Human</td><td align="center" valign="middle" rowspan="1" colspan="1">Hepatocellular carcinoma</td><td align="center" valign="middle" rowspan="1" colspan="1">28.5 <break/>17.1&#x02013;37.3</td><td align="center" valign="middle" rowspan="1" colspan="1">0.03 <break/>0.01&#x02013;0.2</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HL-60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Human</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Promyelocytic leukemia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17.8 <break/>14.6&#x02013;21.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.04 <break/>0.02&#x02013;0.08</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Non-cancer cell</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MRC-5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Human</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lung fibroblast</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25.8 <break/>22.0&#x02013;30.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2 <break/>0.1&#x02013;0.5</td></tr></tbody></table><table-wrap-foot><fn><p>Data are presented as IC<sub>50</sub> values, in &#x003bc;g/mL, with respective 95% confidence interval obtained by nonlinear regression from at least three independent experiments performed in duplicate, measured by Alamar blue assay after 72 h of treatment. Doxorubicin (DOX) was used as the positive control.</p></fn></table-wrap-foot></table-wrap><table-wrap id="molecules-23-02974-t003" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-23-02974-t003_Table 3</object-id><label>Table 3</label><caption><p>Effect of the essential oil (EO) from the leaves of <italic>Croton matourensis</italic> on body and relative organ weight from C.B-17 SCID mice with HepG2 cell xenografts.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Parameters</th><th align="center" valign="top" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">CTL</th><th align="center" valign="top" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">5-FU</th><th colspan="2" align="center" valign="top" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">EO</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Dose (mg/kg/day)</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">10</td><td align="center" valign="top" rowspan="1" colspan="1">40</td><td align="center" valign="top" rowspan="1" colspan="1">80</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Initial body weight (g)</td><td align="center" valign="top" rowspan="1" colspan="1">21.4 &#x000b1; 0.5</td><td align="center" valign="top" rowspan="1" colspan="1">19.6 &#x000b1; 0.6</td><td align="center" valign="top" rowspan="1" colspan="1">22.0 &#x000b1; 0.5</td><td align="center" valign="top" rowspan="1" colspan="1">19.9 &#x000b1; 0.6</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Final body weight (g)</td><td align="center" valign="top" rowspan="1" colspan="1">22.1 &#x000b1; 0.5</td><td align="center" valign="top" rowspan="1" colspan="1">20.5 &#x000b1; 0.5</td><td align="center" valign="top" rowspan="1" colspan="1">21.0 &#x000b1; 0.3</td><td align="center" valign="top" rowspan="1" colspan="1">20.9 &#x000b1; 0.4</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Liver (g/100 g body weight)</td><td align="center" valign="top" rowspan="1" colspan="1">4.8 &#x000b1; 0.2</td><td align="center" valign="top" rowspan="1" colspan="1">4.8 &#x000b1; 0.2</td><td align="center" valign="top" rowspan="1" colspan="1">5.0 &#x000b1; 0.3</td><td align="center" valign="top" rowspan="1" colspan="1">5.2 &#x000b1; 0.3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Kidney (g/100 g body weight)</td><td align="center" valign="top" rowspan="1" colspan="1">1.5 &#x000b1; 0.1</td><td align="center" valign="top" rowspan="1" colspan="1">1.5 &#x000b1; 0.1</td><td align="center" valign="top" rowspan="1" colspan="1">1.4 &#x000b1; 0.1</td><td align="center" valign="top" rowspan="1" colspan="1">1.5 &#x000b1; 0.1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Heart (g/100 g body weight)</td><td align="center" valign="top" rowspan="1" colspan="1">0.5 &#x000b1; 0.1</td><td align="center" valign="top" rowspan="1" colspan="1">0.6 &#x000b1; 0.1</td><td align="center" valign="top" rowspan="1" colspan="1">0.6 &#x000b1; 0.1</td><td align="center" valign="top" rowspan="1" colspan="1">0.5 &#x000b1; 0.1</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Lung (g/100 g body weight)</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">0.8 &#x000b1; 0.1</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">0.8 &#x000b1; 0.1</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">0.8 &#x000b1; 0.1</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">0.7 &#x000b1; 0.1</td></tr></tbody></table><table-wrap-foot><fn><p>Beginning 1 day after tumor implantation, the animals were treated through the intraperitoneal route for 21 consecutive days. The negative control (CTL) was treated with the vehicle (5% DMSO) used for diluting the EO. 5-Fluorouracil (5-FU, 10 mg/kg/day) was used as the positive control. Data are presented as means &#x000b1; SEM. of 10&#x02013;20 animals.</p></fn></table-wrap-foot></table-wrap><table-wrap id="molecules-23-02974-t004" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-23-02974-t004_Table 4</object-id><label>Table 4</label><caption><p>Effect of the essential oil (EO) from the leaves of <italic>Croton matourensis</italic> on hematological parameters of peripheral blood from C.B-17 SCID mice with HepG2 cell xenografts.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Parameters</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">CTL</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">5-FU</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">EO</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Dose (mg/kg/day)</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">10</td><td align="center" valign="middle" rowspan="1" colspan="1">40</td><td align="center" valign="middle" rowspan="1" colspan="1">80</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Erythrocytes (10<sup>6</sup>/mm<sup>3</sup>)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.2 &#x000b1; 1.1</td><td align="center" valign="middle" rowspan="1" colspan="1">7.6 &#x000b1; 0.8</td><td align="center" valign="middle" rowspan="1" colspan="1">4.9 &#x000b1; 1.2</td><td align="center" valign="middle" rowspan="1" colspan="1">7.6 &#x000b1; 1.1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Hemoglobin (g/dL)</td><td align="center" valign="middle" rowspan="1" colspan="1">21.2 &#x000b1; 4.8</td><td align="center" valign="middle" rowspan="1" colspan="1">17.7 &#x000b1; 3.1</td><td align="center" valign="middle" rowspan="1" colspan="1">26.9 &#x000b1; 0.7</td><td align="center" valign="middle" rowspan="1" colspan="1">17.7 &#x000b1; 2.2</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Hematocrit (%)</td><td align="center" valign="middle" rowspan="1" colspan="1">22.0 &#x000b1; 4.7</td><td align="center" valign="middle" rowspan="1" colspan="1">38.9 &#x000b1; 0.3</td><td align="center" valign="middle" rowspan="1" colspan="1">9.5 &#x000b1; 0.3</td><td align="center" valign="middle" rowspan="1" colspan="1">40.1 &#x000b1; 1.4</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MCV (fL)</td><td align="center" valign="middle" rowspan="1" colspan="1">43.8 &#x000b1; 0.4</td><td align="center" valign="middle" rowspan="1" colspan="1">45.0 &#x000b1; 3.0</td><td align="center" valign="middle" rowspan="1" colspan="1">42.0 &#x000b1; 0.0</td><td align="center" valign="middle" rowspan="1" colspan="1">45.3 &#x000b1; 0.5</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Platelets (10<sup>3</sup>/mm<sup>3</sup>)</td><td align="center" valign="middle" rowspan="1" colspan="1">247.2 &#x000b1; 38.5</td><td align="center" valign="middle" rowspan="1" colspan="1">222.1 &#x000b1; 41.6</td><td align="center" valign="middle" rowspan="1" colspan="1">519.3 &#x000b1; 136.6</td><td align="center" valign="middle" rowspan="1" colspan="1">279.7 &#x000b1; 37.2</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leukocytes (10<sup>3</sup>/mm<sup>3</sup>)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.2 &#x000b1; 0.8</td><td align="center" valign="middle" rowspan="1" colspan="1">2.5 &#x000b1; 0.6</td><td align="center" valign="middle" rowspan="1" colspan="1">7.1 &#x000b1; 0.6</td><td align="center" valign="middle" rowspan="1" colspan="1">3.5 &#x000b1; 0.5</td></tr><tr><td colspan="3" align="left" valign="middle" rowspan="1">Differential leukocytes (%)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Granulocytes</td><td align="center" valign="middle" rowspan="1" colspan="1">24.1</td><td align="center" valign="middle" rowspan="1" colspan="1">28.4</td><td align="center" valign="middle" rowspan="1" colspan="1">26.8</td><td align="center" valign="middle" rowspan="1" colspan="1">26.7</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Lymphocytes</td><td align="center" valign="middle" rowspan="1" colspan="1">41.5</td><td align="center" valign="middle" rowspan="1" colspan="1">46.1</td><td align="center" valign="middle" rowspan="1" colspan="1">45.4</td><td align="center" valign="middle" rowspan="1" colspan="1">51.7</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Monocytes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21.7</td></tr></tbody></table><table-wrap-foot><fn><p>Beginning 1 day after tumor implantation, the animals were treated through the intraperitoneal route for 21 consecutive days. The negative control (CTL) was treated with the vehicle (5% DMSO) used for diluting the EO. 5-Fluorouracil (5-FU, 10 mg/kg/day) was used as the positive control. Data are presented as means &#x000b1; SEM. of 7&#x02013;14 animals. MCV: Mean corpuscular volume.</p></fn></table-wrap-foot></table-wrap></floats-group></article>